{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-25-000092","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.963777+00:00","generated_at":"2026-05-17T20:35:15.856989+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OrthoPediatrics Q2 revenue hits record $61.1M (+16% YoY); raises FY2025 guidance","bullets":["Revenue of $61.1M (+16% YoY); domestic up 17%, international up 12%.","Adjusted EBITDA $4.1M (+58% YoY); non-GAAP EPS improved to ($0.11) from ($0.23).","Raised FY2025 revenue guidance to $237-242M from $236-242M; reaffirmed adjusted EBITDA $15-17M.","Scoliosis revenue +35% to $18.5M; Trauma & Deformity +10% to $41.7M.","OPSB expanded with new clinics, entry into Ireland for first international operation."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-25-000092","json":"https://secwatch.observer/filing/0001425450-25-000092.json","markdown":"https://secwatch.observer/filing/0001425450-25-000092.md","text":"https://secwatch.observer/filing/0001425450-25-000092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545025000092/0001425450-25-000092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545025000092/kids-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:35:15.856989+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}